Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 5
2001 2
2002 4
2003 1
2004 6
2005 7
2006 6
2007 5
2008 5
2009 6
2010 5
2011 4
2012 2
2013 7
2014 6
2015 4
2016 4
2017 2
2018 7
2019 4
2020 4
2021 7
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

95 results
Results by year
Filters applied: . Clear all
Page 1
Hepatitis B: Who and when to treat?
Vlachogiannakos J, Papatheodoridis GV. Vlachogiannakos J, et al. Liver Int. 2018 Feb;38 Suppl 1:71-78. doi: 10.1111/liv.13631. Liver Int. 2018. PMID: 29427495 Review.
New epidemiology of hepatitis delta.
Vlachogiannakos J, Papatheodoridis GV. Vlachogiannakos J, et al. Liver Int. 2020 Feb;40 Suppl 1:48-53. doi: 10.1111/liv.14357. Liver Int. 2020. PMID: 32077599 Review.
Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S, Michaelides C, Voulgaris T, Vlachogiannakos J, Manesis E, Tiniakos DG, Delladetsima I. Sakellariou S, et al. Among authors: vlachogiannakos j. Virchows Arch. 2021 Oct;479(4):815-824. doi: 10.1007/s00428-021-03152-z. Epub 2021 Jul 27. Virchows Arch. 2021. PMID: 34312700 Free PMC article.
Recent advances in cirrhotic cardiomyopathy.
Karagiannakis DS, Papatheodoridis G, Vlachogiannakos J. Karagiannakis DS, et al. Among authors: vlachogiannakos j. Dig Dis Sci. 2015 May;60(5):1141-51. doi: 10.1007/s10620-014-3432-8. Epub 2014 Nov 18. Dig Dis Sci. 2015. PMID: 25404411 Review.
Correction to: Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S, Michaelides C, Voulgaris T, Vlachogiannakos J, Manesis E, Tiniakos DG, Delladetsima I. Sakellariou S, et al. Among authors: vlachogiannakos j. Virchows Arch. 2021 Oct;479(4):825-826. doi: 10.1007/s00428-021-03181-8. Virchows Arch. 2021. PMID: 34463824 Free PMC article. No abstract available.
Serum zonulin levels in patients with liver cirrhosis: Prognostic implications.
Voulgaris TA, Karagiannakis D, Hadziyannis E, Manolakopoulos S, Karamanolis GP, Papatheodoridis G, Vlachogiannakos J. Voulgaris TA, et al. Among authors: vlachogiannakos j. World J Hepatol. 2021 Oct 27;13(10):1394-1404. doi: 10.4254/wjh.v13.i10.1394. World J Hepatol. 2021. PMID: 34786174 Free PMC article.
HBV: Do I treat my immunotolerant patients?
Vlachogiannakos J, Papatheodoridis GV. Vlachogiannakos J, et al. Liver Int. 2016 Jan;36 Suppl 1:93-9. doi: 10.1111/liv.12996. Liver Int. 2016. PMID: 26725904 Review.
Assessment of dietary habits and the adequacy of dietary intake of patients with cirrhosis-the KIRRHOS study.
Georgiou A, Yannakoulia M, Papatheodoridis GV, Deutsch M, Alexopoulou A, Vlachogiannakos J, Ioannidou P, Papageorgiou MV, Voulgaris T, Papadopoulos N, Tsibouris P, Kontogianni MD. Georgiou A, et al. Among authors: vlachogiannakos j. Clin Nutr. 2021 Jun;40(6):3992-3998. doi: 10.1016/j.clnu.2021.04.044. Epub 2021 May 7. Clin Nutr. 2021. PMID: 34139472
95 results